ANNA WALLEY: Open Payments
NPI 1528373586 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,067 in 149 payments from 25 companies in 2025. Trend: 2023 $4,956 · 2024 $4,529 · 2025 $3,067
Food & beverage: $3,067
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 37 | $751 |
| Inspire Medical Systems, Inc. | 9 | $515 |
| AstraZeneca Pharmaceuticals LP | 18 | $346 |
| Mallinckrodt Hospital Products Inc. | 16 | $269 |
| Verona Pharma, Inc. | 17 | $160 |
| GENZYME CORPORATION | 7 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $132 |
| JAZZ PHARMACEUTICALS INC. | 4 | $103 |
| Insmed, Inc. | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
Products named: INSPIRE, NUCALA, TRELEGY ELLIPTA, ACTHAR, DUPIXENT, Ohtuvayre, AIRSUPRA, XYWAV.
Industry payments across MS — which companies pay providers there.
